Unlocking the potential of monoclonal antibodies
An experimental Alzheimer's drug, hailed as a breakthrough, slowed cognition decline in people with early-stage disease, according to a new study in the New England Journal of Medi…
An experimental Alzheimer's drug, hailed as a breakthrough, slowed cognition decline in people with early-stage disease, according to a new study in the New England Journal of Medi…